Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AvitaROCO:4735 +0.82%73 Gross Margin % is 30.38% as of Dec. 2025, which is 3% above its 10-year median of 29.36. GuruFocus rates ROCO:4735 with a GF Score™ of 73/100 and a GF Value™ of NT$31.75 (Fairly Valued). The stock has 7 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Avita ranks worse than 79.28% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Avita's Gross Profit for the
three
months ended in Dec. 2025 was NT$75.4 Mil. Avita's Revenue for the
three
months ended in Dec. 2025 was NT$248.0 Mil. Therefore, Avita's Gross Margin % for the quarter that ended in Dec. 2025 was 30.38%.
Warning Sign:
Avita Corp gross margin has been in long-term decline. The average rate of decline per year is -2.4%.
The historical rank and industry rank for Avita's Gross Margin % or its related term are showing as below:
ROCO:4735'
s Gross Margin % Range Over the Past 10 Years
Min: 25.14 Med: 29.36 Max: 36.17
Current: 31.58
During the past 13 years, the highestGross Margin % of Avita was 36.17%. The lowest was 25.14%. And the median was 29.36%.
ROCO:4735's Gross Margin % is ranked worse than 79.28% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 52.115
vs ROCO:4735: 31.58
Avita had a gross margin of 30.38% for the quarter that ended in Dec. 2025 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Avita was -2.40% per year.
Avita (ROCO:4735) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Avita had a gross margin of 30.38% for the quarter that ended in Dec. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Avita Gross Margin % Related Terms
Avita Gross Margin % Historical Data
* Premium members only.
The historical data trend for Avita's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4735 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Avita's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avita Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avita's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Avita's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Avita (ROCO:4735) has a Gross Margin % of 30.38% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Avita and its competitors. This is near median its historical median of 29.36. Over the past decade, Avita's Gross Margin % has ranged from 25.14 to 36.17. According to the industry distribution chart, Avita ranks #639 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 79.3%.
Is Avita's Gross Margin % too high?
Avita's current Gross Margin % of 30.38% is near median its 10-year median of 29.36. Over the past 10 years, this metric has ranged from a low of 25.14 to a high of 36.17. The Medical Devices & Instruments industry median Gross Margin % is 52.12. Avita's value of 30.38% is 41.7% below this industry median. Based on the distribution chart, Avita ranks #639 out of 806 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Avita has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Avita's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Avita ranks #639 out of 806 companies for Gross Margin %. This places Avita in the lower half of its industry. The industry median Gross Margin % is 52.12. Avita's value of 30.38% is 41.7% below this benchmark. Historically, Avita's own Gross Margin % has ranged from 25.14 to 36.17 over the past decade. While the company's 10-year median is 29.36 vs. the industry median of 52.12, Avita has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.12, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avita's current Gross Margin % of 30.38% is 41.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Avita and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avita's current Gross Margin % is 30.38%, which is near median its own 10-year median of 29.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avita stock overvalued right now?
Based on GuruFocus' analysis, Avita (ROCO:4735) is currently considered Fairly Valued. The stock's GF Value™ is NT$31.75, compared to a current price of NT$30.90 — trading 2.7% below its estimated fair value. The current Gross Margin % is 30.38%, which is near median its 10-year median of 29.36 and 41.7% below the Medical Devices & Instruments industry median of 52.12. Avita's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Avita (ROCO:4735), the current Gross Margin % is 30.38% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avita (ROCO:4735) Overvalued in 2026?
Based on GuruFocus' analysis, Avita stock appears to be undervalued.
The current stock price of NT$30.90 is trading 2.7% below its estimated GF Value™ of NT$31.75.
GuruFocus considers Avita to be Fairly Valued.
Key valuation signals for ROCO:4735:
Gross Margin %: 30.38% (near median its 10-year median of 29.36)
GF Value™: NT$31.75 vs. price of NT$30.90 (2.7% below fair value)
Industry Position: 41.7% below the Medical Devices & Instruments median (#639 of 806)
No single metric tells the full story. See the ROCO:4735 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avita Corp is a manufacturer of point-of-care health products designed for clinical and personal use. The company provides body composition analyzers, blood pressure monitors, blood glucose monitors, digital thermometers, and nasal care devices. Its products include a thermometer, nasal aspirator, blood pressure monitor arm, and wrist.
73GF Score
Get the complete analysis for ROCO:4735
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4735 has been successfully added to your 
